KRIYA Trademark

Trademark Overview


On Friday, March 10, 2023, a trademark application was filed for KRIYA with the United States Patent and Trademark Office. The USPTO has given the KRIYA trademark a serial number of 97833365. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 4, 2024. This trademark is owned by Kriya Therapeutics, Inc.. The KRIYA trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; providing technical information in the field of pharmaceutical manufacturing

Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders
kriya

General Information


Serial Number97833365
Word MarkKRIYA
Filing DateFriday, March 10, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 9, 2024

Trademark Statements


Goods and ServicesBiomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; providing technical information in the field of pharmaceutical manufacturing
Description of MarkThe mark consists of the stylized wording "KRIYA".
Goods and ServicesPharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesTesting, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 31, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, March 31, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 31, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKriya Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Party NameKriya Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306

Trademark Events


Event DateEvent Description
Tuesday, March 14, 2023NEW APPLICATION ENTERED
Friday, March 31, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 7, 2023ASSIGNED TO EXAMINER
Thursday, December 14, 2023NON-FINAL ACTION WRITTEN
Thursday, December 14, 2023NON-FINAL ACTION E-MAILED
Thursday, December 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 1, 2024ASSIGNED TO EXAMINER
Friday, March 1, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, March 1, 2024EXAMINERS AMENDMENT E-MAILED
Friday, March 1, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 1, 2024EXAMINER'S AMENDMENT ENTERED
Monday, March 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT